The FDA has approved Tezspire (tezepelumab-ekko) for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately controlled chronic rhinosinusitis with ...
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
One Chicago-area woman opted for an oncoplastic reduction, which combined breast cancer surgery with the aesthetics of a lift ...
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- ...
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 ...
The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...
Sportschosun on MSN
Tricky rectal cancer, anal preservation surgery without stoma?
Colorectal cancer is the third most common cancer in Korea, and the cancer mortality rate is fatal enough to rank third.
MedPage Today on MSN
Eye Manifestation in Crohn's; Night-Time Reflux Relief; Behavioral Therapies for IBS
Vonoprazan (Voquezna) demonstrated benefit for night-time symptoms of non-erosive reflux disease in an analysis of phase III ...
As many as 80% of women will have uterine fibroids in their lifetime. Too many of them will undergo a hysterectomy, experts ...
Abstract: Colorectal cancer is one of the deadliest cancers today, but it can be prevented through early detection of malignant polyps in the colon, primarily via ...
Bleeding after sex is more common than you would probably think, and is rarely a cause of concern. Often, it's due to vaginal dryness or vigorous sex.
Abstract: The segmentation of polyps is crucial to the early detection and diagnosis of colorectal cancer. However, obtaining accurate segmentation often requires labor-intensive annotations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results